Vertex Pharmaceuticals (VRTX) EBIT Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 530.00 |
| Dec 31, 2025 | -708.00 |
| Sep 30, 2025 | -971.00 |
| Jun 30, 2025 | -1,155.00 |
| Mar 31, 2025 | -2,688.00 |
| Dec 31, 2024 | -711.00 |
| Sep 30, 2024 | -1,288.00 |
| Jun 30, 2024 | -13,074.00 |
| Mar 31, 2024 | -914.00 |
| Dec 31, 2023 | -655.00 |
| Sep 30, 2023 | -190.00 |
| Jun 30, 2023 | -593.00 |
| Mar 31, 2023 | -1,473.00 |
| Dec 31, 2022 | -30,907.00 |
| Sep 30, 2022 | 3,781.00 |
| Jun 30, 2022 | 2,169.00 |
| Mar 31, 2022 | 1,738.00 |
| Dec 31, 2021 | 2,767.00 |
| Sep 30, 2021 | 2,693.00 |
| Jun 30, 2021 | -2,510.00 |
| Mar 31, 2021 | 3,137.00 |
| Dec 31, 2020 | 2,652.00 |
| Sep 30, 2020 | 10,009.00 |
| Jun 30, 2020 | 3,741.00 |
| Mar 31, 2020 | 964.00 |
| Dec 31, 2019 | 34,532.00 |
| Sep 30, 2019 | 1,503.00 |
| Jun 30, 2019 | 2,789.00 |
| Mar 31, 2019 | 3,585.00 |
| Dec 31, 2018 | 2,789.00 |
| Sep 30, 2018 | 4,936.00 |
| Jun 30, 2018 | 12,605.00 |
| Mar 31, 2018 | 15,153.00 |
| Dec 31, 2017 | 12,557.00 |
| Sep 30, 2017 | 4,733.00 |
| Jun 30, 2017 | 15,729.00 |
| Mar 31, 2017 | 22,028.00 |
| Dec 31, 2016 | 1,662.00 |
| Sep 30, 2016 | 5,116.00 |
| Jun 30, 2016 | 1,925.00 |
| Mar 31, 2016 | 12,709.00 |
| Dec 31, 2015 | 999.00 |
| Sep 30, 2015 | -2,283.00 |
| Jun 30, 2015 | -10,049.00 |
| Mar 31, 2015 | -15,583.00 |
| Dec 31, 2014 | -14,602.00 |
| Sep 30, 2014 | -15,513.00 |
| Mar 31, 2014 | 3,468.00 |
| Dec 31, 2013 | 24,633.00 |
| Sep 30, 2013 | 78,305.00 |
| Jun 30, 2013 | 51,779.00 |
| Mar 31, 2013 | 58,393.00 |
| Dec 31, 2012 | 40,974.00 |
| Sep 30, 2012 | 59,363.00 |
| Jun 30, 2012 | 82,184.00 |
| Mar 31, 2012 | 69,956.00 |